| Application no. and date | 11002017.9 (espacenet) (Federated) (European Patent Register), 20050518 | | Patent/reg. no. and date | DK/EP 2380903, 20170405 | | Publication date | 20111026 | | Priority no. and date | DE 102004024617, 20040518 | | EP pub. no. and date |
EP 2380903 20111026 | | Effective date | | | Applicant/owner | Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome,
Chuo-ku
Tokyo 103-8411, JP | | Applicant ref. no. | V1705-035 | | Inventor | TÜRECI, Özlem, Philipp-von-Zabern-Platz 1
55116 Mainz, DE,
SAHIN, Ugur, Philipp-von-Zabern Platz 1
55116 Mainz, DE,
FRITZ, Stefan, Geisterweg 35
55237 Flonheim, DE,
KOSLOWSKI, Michael, Autogenstrasse 50
65933 Frankfurt, DE,
Geppert, Harald-Gerhard, Grünstrasse 46
42697 Solingen, DE | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 14/47 (2006.01) , C07K 16/30 (2006.01) | | Title | GENPRODUKTER, DER UDTRYKKES DIFFERENTIELT I TUMORER OG ANVENDELSE DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
